News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Olanzapine vs fosaprepitant: Which is better for CINV prevention?
09 May 2024
byAudrey Abella
Olanzapine appears to be just as effective as fosaprepitant, a neurokinin-1 receptor antagonist (NK1-RA), in controlling chemotherapy-induced nausea and vomiting (CINV) in patients with gynaecologic malignancies who were receiving carboplatin/paclitaxel chemotherapy every 3 weeks, a prospective study presented at SGO 2024 suggests. However, the former trumps the latter in terms of cost effectiveness.
09 May 2024

Do IBD patients have a need for mental health care?
02 May 2024
A recent study suggests greater focus must be given on depression or anxiety symptoms than an actual diagnosis of these psychological disorders in predicting who among people with inflammatory bowel disease (IBD) will have a need for mental health care.
02 May 2024






